Align maintained by JMP at market perform

Align Technology, Inc. was maintained by JMP Securities analyst Anthony Ostrea at a market outperform rating after the company filed a complaint against OrthoClear for patent infringement of 12 Align patents, possibly based on the use of digital datasets in developing and manufacturing aligners, JMP said. The case, filed with the International Trade Commission, could be resolved in 12 to 18 months. Infringement on even one claim would allow the company to block importation of OrthoClear's product in the United States. But Align's near-term market share is unclear, JMP said. Shares of the Santa Clara, Calif., medical instruments company were up 60 cents, or 9.60%, at $6.85 on volume of 1,346,669 shares versus the three-month running average of 615,680 shares. (Nasdaq: ALGN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.